Our Story

For more than 75 years, Ortho Clinical Diagnostics has been guided by its purpose: to improve and save lives with diagnostics.

Timeline

Discover important moments throughout Ortho Clinical Diagnostic’s rich history of pioneering life-impacting advances.

Timeline

Discover important moments throughout Ortho Clinical Diagnostic’s rich history of pioneering life-impacting advances.

Innovation |

VITROS® XT Chemistry Product Slides

Multi-test technology allows labs to run two frequently ordered tests simultaneously on one slide.

Innovation |

VITROS® High Sensitivity Troponin I assay gets CE Mark

Helps more rapidly and accurately identify patients suffering from a heart attack.

Product Launch |

VITROS® XT 7600 Integrated System

Enables powerful data intelligence, operational improvements and other enhancements in the lab.

Award |

The Trailblazer Company of the Year

Honor by PM360 recognizes impact in the health care industry through innovation, social responsibility and talent development.

Award |

Gold-level Edison Award

Ortho’s VITROS® NEPHROCHECK® Test recognized with a gold-level Edison Award™ in the Best New Product Awards™ category

Product Launch |

ORTHO CONNECT™ V2.0 Middleware

Ortho Clinical Diagnostics receives CE Mark approval for ORTHO CONNECT™ V2.0 Middleware Solution

Award |

Edison Award™ for Outstanding Product Innovation

Ortho receives an Edison Award™ for Global Product Innovation, for its ORTHO VISION® Platform of fully automated analyzers, which test blood for compatibility before it is used in transfusions

Product Launch |

China FDA approves ORTHO VISION Platform

The ORTHO VISION® Platform of fully automated blood analyzers for low-, mid- and high-volume transfusion medicine laboratories receives approval by the China Food and Drug Administration

Product Launch |

U.S. FDA clears ORTHO VISION Max

The U.S. FDA clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs, making it commercially available in the U.S.

Product Launch |

U.S. FDA clears VITROS Automation Solutions

The U.S. FDA clears VITROS® Automation Solutions for use with Ortho’s VITROS® Chemistry, Immunodiagnostics and Integrated Systems, allowing U.S. clinical laboratories to improve results throughout diagnostic testing

Innovation |

HIV Combo Test

Ortho Clinical Diagnostics receives CE Mark approval for its Immunodiagnostic HIV Combo Test, making it commercially available in those countries that accept CE Mark

Product Launch |

ORTHO VISION™ Analyzer available in U.S.

Ortho Clinical Diagnostics receives 510(k) clearance for ORTHO VISION™ Analyzer, making it commercially available in the United States. ORTHO VISION™ Analyzer automates the full range of immunohematology testing and helps improve the safety of blood transfusions by reducing the lab's reliance on manual methods

Product Launch |

VITROS Automation Solutions released in EU and non-regulated markets

VITROS® Automation Solutions released in EU and non-regulated markets

Product Launch |

ORTHO VISION® Max gets CE Mark

Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs, becoming commercially available in Europe and Japan

Commercial |

The Carlyle Group acquires Ortho Clinical Diagnostics from Johnson & Johnson

The Carlyle Group acquires Ortho Clinical Diagnostics from Johnson & Johnson

Event |

Ortho Hosts 4th Annual Hospital C-Suite Summit in Singapore

Ortho Clinical Diagnostics Hosts 4th Annual Hospital C-Suite Summit in Singapore

Product Launch |

Ortho Clinical Diagnostics receives CE Mark for ORTHO VISION

Ortho Clinical Diagnostics receives CE Mark for ORTHO VISION™ Analyzer, making it commercially available in Europe, Japan and Australia

Product Launch |

Ortho Clinical Diagnostics launches ORTHO Workstation

Ortho Clinical Diagnostics launches ORTHO™ Workstation, a next-generation semi-automated blood typing system

Product Launch |

Ortho Clinical Diagnostics launches the VITROS® 4600 Chemistry System

Ortho Clinical Diagnostics launches the VITROS® 4600 Chemistry System for mid- to high-volume laboratories

Product Launch |

Ortho Clinical Diagnostics launches the VITROS® 5600 Integrated System

Ortho Clinical Diagnostics launches the VITROS® 5600 Integrated System, which integrates clinical chemistry and immunoassay testing, and the VITROS® 3600 Immunodiagnostic System

Innovation |

Ortho Clinical Diagnostics launches the first FDA-licensed test to screen blood donations for exposure to Chagas' disease

Ortho Clinical Diagnostics launches the first FDA-licensed test to screen blood donations for exposure to Chagas' disease

Product Launch |

Ortho Clinical Diagnostics launches the VITROS® 350 Chemistry System

Ortho Clinical Diagnostics launches the VITROS® 350 Chemistry System

Product Launch |

Ortho Clinical Diagnostics launches the VITROS® 5, 1 FS Chemistry System

Ortho Clinical Diagnostics launches the VITROS® 5, 1 FS Chemistry System, raising industry standards for ease-of-use, integrity of results, and operational efficiency

Product Launch |

Ortho Clinical Diagnostics launches the VITROS® ECiQ Immunodiagnostic System and the ORTHO AutoVue® Innova System

Ortho Clinical Diagnostics launches the VITROS® ECiQ Immunodiagnostic System and the ORTHO AutoVue® Innova System

Product Launch |

Ortho Clinical Diagnostics launches ORTHO ProVue® Analyzer

Ortho Clinical Diagnostics launches ORTHO ProVue® Analyzer, the first fully automated immunohematology system for use with the ID-Micro Typing System™ (ID-MTS) Gel Test in North America

Commercial |

Ortho Clinical Diagnostics acquires Micro Typing Systems of Pompano Beach

Ortho Clinical Diagnostics acquires Micro Typing Systems of Pompano Beach, Florida, the manufacturer of the ID-Micro Typing System™ (ID-MTS) used in hospitals and donor centers to help to ensure safe and effective blood transfusions

Innovation |

Ortho Clinical Diagnostics becomes the first diagnostic company to receive US FDA approval for automated random access hepatitis tests, on the VITROS® ECi Immunodiagnostic System

Ortho Clinical Diagnostics becomes the first diagnostic company to receive US FDA approval for automated random access hepatitis tests, on the VITROS® ECi Immunodiagnostic System (for diagnostic use only; not for blood screening)

Innovation |

Ortho Clinical Diagnostics develops Ortho trak-C™

Ortho Clinical Diagnostics develops Ortho trak-C™, the world’s first branded “Total HCV Core Antigen” test designed to provide reliable measures of HCV viremia

|

Ortho Clinical Diagnostics releases the HCV Core Antigen ELISA Test System

Ortho Clinical Diagnostics releases the HCV Core Antigen ELISA Test System—the first test commercially available for the direct detection in blood and plasma of HCV core antigen, a marker of early infection in hepatitis C–infected individuals

|

Ortho Clinical Diagnostics becomes one of the first diagnostic industry suppliers to offer contracted implementation services

Ortho Clinical Diagnostics becomes one of the first diagnostic industry suppliers to offer contracted implementation services that can significantly reduce clinical laboratory costs through operational efficiencies and streamlined processes

|

Ortho Clinical Diagnostics introduces the ORTHO AutoVue® System

Ortho Clinical Diagnostics introduces the ORTHO AutoVue® System, the first fully automated blood banking system in Europe

|

Ortho Clinical Diagnostics is formed from the merger of two Johnson & Johnson companies

Ortho Clinical Diagnostics is formed from the merger of two Johnson & Johnson companies: Ortho Diagnostic Systems, a worldwide leader in transfusion medicine reagents and instrument systems, and Johnson & Johnson Clinical Diagnostics (formerly a division of Eastman Kodak Co.), a worldwide leader in clinical laboratory systems

|

Ortho Products introduces VITROS ECi Immunodiagnostic System

Ortho Products introduces the most advanced immunodiagnostic system available in the industry, the VITROS® ECi Immunodiagnostic System

|

Ortho Clinical Diagnostics introduces the Ortho Summit™ System

Ortho Clinical Diagnostics introduces the Ortho Summit™ System, the first fully automated blood and plasma screening system available in the US

|

Ortho Products introduces the first test for the detection of antibodies to hepatitis C

Ortho Products introduces the first test for the detection of antibodies to hepatitis C

|

Ortho Products introduces patented thin-film dry slide technology

Ortho Products introduces patented thin-film dry slide technology, once again revolutionizing the field of diagnostics by providing clinical professionals with the means to receive high-quality results quickly, cleanly, and economically

|

Ortho Products develops the first blood bank anti-D test for the clinical market

Ortho Products develops the first blood bank anti-D test for the clinical market. This is a revolutionary advance in the burgeoning blood banking industry.

|

Dr. Philip Levine joins Ortho Products

Dr. Philip Levine, a pioneer in the field of hematology, joins Ortho Products to continue his breakthrough research into the mechanics of the Rh system in human blood. This marks the beginning of the company's commitment to diagnostic medicine. Among Dr. Levine's many contributions is research that leads to the development of Rh immune globulin to protect Rh-negative women against isoimmunization, saving the lives of thousands of babies.

|

Ortho Products, Inc., is formed

Ortho Products, Inc., is formed in Linden, New Jersey, as a division of Johnson & Johnson